Related Experiment Video
Updated: Jul 27, 2026

06:50
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
MOLECULAR-BIOLOGICAL THYROID PROFILE DURING AUTOIMMUNE DISEASE - HASHIMOTO AND RIEDEL'S THYROIDITIS
T Gvianishvili1, L Gogiashvili1, M Chkhobadze2
11Ivane Javakhishvili Tbilisi State University.
Georgian Medical News
|July 20, 2019
Summary
This study examines thyroid gland samples, differentiating between Hashimoto thyroiditis, Graves
Area of Science:
- Endocrinology
- Pathology
- Immunohistochemistry
Background:
- Thyroiditis encompasses several conditions affecting the thyroid gland, including Hashimoto thyroiditis (HT), Riedel thyroiditis (RT), and Graves' disease.
- Understanding the distinct histological and immunohistochemical profiles of these conditions is crucial for accurate diagnosis and management.
- Distinguishing inflammatory thyroid conditions from papillary thyroid carcinoma is essential for appropriate patient treatment.
Purpose of the Study:
- To investigate and compare the histological and immunohistochemical characteristics of Hashimoto thyroiditis, Riedel thyroiditis, Graves' disease, and papillary thyroid carcinoma.
- To identify specific markers and patterns associated with each thyroid condition.
- To assess the utility of immunohistochemistry in differentiating these thyroid pathologies.
Main Methods:
- Analysis of 62 surgical thyroid gland samples: Hashimoto thyroiditis (n=27), Riedel thyroiditis (n=9), Graves' disease (n=17), and papillary thyroid carcinoma (n=10).
- Classical histological examination using Hematoxylin and Eosin (H&E) staining.
- Immunohistochemical analysis employing markers: TTF-1, TSH, S100-protein, CD56, and p63.
Main Results:
- Hashimoto thyroiditis and Riedel thyroiditis show histological heterogeneity with progressive fibrosis; Hashimoto thyroiditis exhibits follicular epithelium dysplasia (p63 positive, CD56 negative).
- Graves' disease is characterized by high TSH expression and lymphoproliferation forming nodules with germinative centers.
- Riedel thyroiditis shows moderate TTF-1 expression in stroma/endotheliocytes and S100 protein in neuroectodermal cells; CD56 and p63 are negative, ruling out malignancy.
Conclusions:
- Distinct histological and immunohistochemical features differentiate Hashimoto thyroiditis, Graves' disease, and Riedel thyroiditis.
- Immunohistochemistry, particularly markers like p63 and CD56, aids in distinguishing inflammatory thyroiditis from malignant conditions.
- Riedel thyroiditis displays specific immunohistochemical patterns and lacks markers associated with malignant transformation.

